Table 1.
Demographical, clinical, and psychological characteristics of the patients.
| Variable | TLE (n = 35) |
|---|---|
| Demographical and clinical data | |
| Gender (f/m) | 13f/22 m |
| Educational level (y) | 13 (8-18) |
| Age (y) | 40.7 ± 12.1 |
| Age at onset (y) | 25.0 ± 13.5 |
| Duration (y) | 15.1 ± 8.7 |
| Antecedent FCs, n | 5 |
| Interictal EEG, n | |
| Unilateral right | 8 |
| Unilateral left | 6 |
| Bilateral | 13 |
| Normal | 5 |
| Radiological hippocampal sclerosis, n | |
| Right | 5 |
| Left | 6 |
| Bilateral | 0 |
| None | 15 |
| Aura, n | 15 |
| AEDs, n | |
| Monotherapy | 15 |
| Multitherapy | 20 |
| Psychiatric therapy (BDZ, SSRI, SNRI, and NL) | 9 |
| Psychological data | |
| MMSE | 28.5 ± 1.5 |
| BDI | 11.94 ± 12.38 |
| STAI—state anxiety | 37.40 ± 12.46 |
| STAI—trait anxiety | 37.37 ± 12.54 |
Legend: BDZ: Benzodiazepine; SSRI: Selective Serotonin Reuptake Inhibitor; SNRI: Serotonin-Norepinephrine Reuptake Inhibitor; NL: Neuroleptic; MMSE: Mini-Mental State Examination (cut-off: >23); BDI: Beck Depression Inventory (cut-off: >12); STAI Y1-Y2: State-Trait Anxiety Inventory 1-2 (cut-off: >40). Data are given as mean values ± SD or median values (range) when appropriate.